Company Directory / Pharmaceuticals
Public · NYSE:AMRXFor profitPharmaceuticalsBridgewater, New Jersey, United States
Amneal Pharmaceuticals manufactures, markets and/or distributes more than 88 drugs in the United States.
Amneal (NASDAQ: AMRX) is rapidly becoming one of the most dynamic, purpose-driven pharmaceutical companies delivering more affordable access to essential medicines. Our family delivers for yours through a robust U.S. generics business, a growing branded business and deepening portfolios in injectables, biosimilars and select international markets. We’ve bolstered our world-class scientific rigor, production capabilities and commercial infrastructure. And we invest substantially in our people through leadership… Read all
Amneal (NASDAQ: AMRX) is rapidly becoming one of the most dynamic, purpose-driven pharmaceutical companies delivering more affordable access to essential medicines. Our family delivers for yours through a robust U.S. generics business, a growing branded business and deepening portfolios in injectables, biosimilars and select international markets. We’ve bolstered our world-class scientific rigor, production capabilities and commercial infrastructure. And we invest substantially in our people through leadership development and employee well-being programs – all so we can deliver even more value. We are Amneal and We make healthy possible. Content is for informational purposes only and 3rd party content does not reflect Amneal’s opinions. Amneal has the right to remove comments that violate another’s copyright or intellectual property, mention an Amneal product, use profanity or are defamatory, promote and solicit for third-party sites, initiatives, or products, or are factually inaccurate or misleading or spam. Amneal recommends that you consult with your healthcare provider regarding personal health matters. To report a product complaint or adverse event related to an Amneal product, contact Drug Safety at 877-835-5472, option 3 or drugsafety@amneal.com. If you are currently experiencing a life-threatening event, please immediately contact 911.
Size
5001-10000 people: larger than 99% of companies with a size listed. 6,473 people list it on LinkedIn.
Age
31 years old.
Reach
Website ranked #453,247 in the world for traffic, about 77k visits a month. 225,149 followers on LinkedIn.
ManufacturingMedicalPharmaceutical
Funding, as listed
$3.2B raised in total
What the source datasets report. We have not watched these rounds ourselves, and do not hold this company in the startups database.
Everything the source datasets list about Amneal Pharmaceuticals, field by field. Contact details are held but never shown.
The company
Where
Size and reach
Funding, as listed
Corporate family
About this record
Growth, as the source summarises it
Amneal Pharmaceuticals may be growing as evidenced by a report indicating shareholders have seen a significant increase in value over the past year, despite a recent pullback. Additionally, the company has been recognized for double-digit growth, leading to an upward revision of its stock target by a securities firm. Amneal has also launched PEMRYDI RTU®, marking the introduction of a new oncology injectable medicine to its product line. Furthermore, the company has received U.S. FDA approval for an over-the-counter Naloxone Hydrochloride Nasal Spray, which is a critical emergency treatment for opioid overdose, and has begun supplying it to U.S. retail pharmacies.
Summaries written by the source dataset, not by us, and not checked.
Pharmaceuticals in United States.
PCI Pharma ServicesPhiladelphia · 5001-10000 people · 71k followersssanofi-aventis U.SBridgewater · 10001+ peopleFrom the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 1,637,054 companies in United States and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.